Holen Sie sich die Stockscreener-App
0.3293
3.99%
-0.0137
Vorhandelsmarkt:
.34
0.0107
+3.25%
Senti Biosciences Holdings Inc Aktie (SNTI) Neueste Nachrichten
Senti Biosciences Holdings, Inc. SEC Filing (Sep 25, 2026) - Stock Titan
Senti Biosciences registers resale of 2.55 crore shares from notes - scanx.trade
Form 4 Senti Biosciences Holdings Inc For: 24 September By Investing.com - Investing.com India
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Senti Biosciences Announces Board and Committee Leadership Change - TipRanks
No cash at closing for Senti Biosciences (NASDAQ: SNTI) shareholders; future payments hinge on milestones. - Stock Titan
No cash at closing in Senti Biosciences (NASDAQ: SNTI)'s proposed merger; payments depend on milestones. - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Form S-3/A SENTI BIOSCIENCES HOLDINGS For: 22 September By Investing.com - Investing.com Canada
Senti Biosciences (SNTI) refreshes auditor sign-off on shelf registration - Stock Titan
Senti Biosciences Inc (NASDAQ: SNTI) Share Price, SNTI Stock News, SNTI Share Price & Updates - kalkine.com.au
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Senti Biosciences (NASDAQ: SNTI) Secures $2.5 Million Stock Purchase at Nasdaq Minimum Price Following Merger - Kalkine Media
Major backer lines up $2.5M for Senti Biosciences (NASDAQ: SNTI) if merger closes - Stock Titan
Convertible notes could hand one investor control of Senti (NASDAQ: SNTI) - Stock Titan
Senti Biosciences Holdings Inc. (SNTI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Senti Biosciences Holds Near $0.34 as SNTI Tests Key Support ZoneStrong Buy Stocks - dars.gov.et
Senti Biosciences Secures Equity Commitment Amid Merger Plans - TipRanks
Senti Biosciences Adds $2 Million Convertible Debt, $2.5 Million Equity Commitment Ahead of Merger - TradingView
Senti Biosciences Holdings, Inc.Common Stock (Nasdaq:SNTI) Stock Quote - The Chronicle-Journal
Senti Biosciences unit issues USD 2 million senior secured convertible notes to NSG BioInnovation Fund - Bitget
Senti Biosciences amends securities agreement, adds note tranche - TipRanks
Senti Biosciences Holdings Received Notice of Noncompliance - TradingView
SNTI Q2'26 Earnings: EPS estimate is (0.27) USD - TradingView
Senti Biosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Senti Biosciences (SNTI) Gains 2.35% as Shares Hold Above Key Support at $0.36Risk Reward Setups - vinanet.vn
Senti Biosciences (SNTI) Slips 4.83% to $0.34, Holds Above Key SupportVolume Dry Up - dars.gov.et
Senti Biosciences (SNTI) Slides 9% as Biotech Sector Headwinds Pressure Micro-Cap StocksSynthetic Short - dars.gov.et
SNTI|Senti Biosciences Inc|Price:0.430|Chg%:+0.000 - TradingKey
SNTI Q1 2026 Earnings: Narrowed Loss Per Share Surpasses Analyst ExpectationsFinancial Summary - careplusvn.com
$Senti Biosciences (SNTI.US)$ - Moomoo
Senti Biosciences Holdings, Inc. SEC Filing (Jul 21, 2026) - Stock Titan
Senti Biosciences (SNTI) Hovers Near Support as Stock Consolidates Below $0.45ETF Outflow Streak - vinanet.vn
Form 13D/A Senti Biosciences Holdings For: 16 July By Investing.com - Investing.com Nigeria
Form S-3/A Senti Biosciences Holdings Inc For: 16 July - Investing.com Nigeria
Form S-3/A Senti Biosciences Holdings Inc For: 16 July By Investing.com - Investing.com South Africa
Senti Biosciences (SNTI) backer plans merger and $6M funding - Stock Titan
Senti Biosciences to spin off gene therapy unit for CVR - Investing.com
Senti Biosciences Holdings Announces Strategic Spin-Off of Gene-Circuit Pipeline and Plans Focus on Regulator Dial Platform - Quiver Quantitative
Senti Biosciences to Divest Operating Business to Celadon Affiliate; Holders Get Up to $60M CVRs - TradingView
Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Te - Yahoo Finance
SNTI Q1 2026 Earnings: Narrow EPS Beat Amid Pre-Revenue Phase; Stock Declines 6.8%Earnings Forecast Report - careplusvn.com
SNTI Should I Buy - Intellectia AI
Price to sales forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Price to book forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Enterprise value to EBITDA forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Enterprise value to EBIT forward of Senti Biosciences Holdings, Inc. – NASDAQ:SNTI - TradingView
Senti Biosciences Holdings Inc Actuals & Estimates (NASDAQ:SNTI) - TradingView
SNTI Forecast — Price Target — Prediction for 2027 - TradingView
SNTI Q1 2026 Earnings: Narrower Loss Surprises Amid Pre-Revenue StageGuidance Accuracy Score - dars.gov.et
Senti Biosciences (SNTI) registers 15.97M shares tied to May 2026 notes - Stock Titan
Senti Biosciences Inc (SNTI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SNTI Q1 2026 Earnings: Modest EPS Beat Amid Development ProgressEarnings Call Transcript - dars.gov.et
Senti Biosciences Inc (SNTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction - Business Wire
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):